Bo Xiao Selected Research

Pilocarpine (Ocusert)

1/2021	The Role of Hippocampal Neurogenesis in ANT-DBS for LiCl-Pilocarpine-Induced Epileptic Rats.
9/2020	The Runx1/Notch1 Signaling Pathway Participates in M1/M2 Microglia Polarization in a Mouse Model of Temporal Lobe Epilepsy and in BV-2 Cells.
7/2020	The study of microtubule dynamics and stability at the postsynaptic density in a rat pilocarpine model of temporal lobe epilepsy.
2/2019	Expression of Nav1.5 in the pathogenesis of temporal lobe epilepsy.
7/2018	The Expression Alteration of BC1 RNA and its Interaction with Eukaryotic Translation Initiation Factor eIF4A Post-Status Epilepticus.
4/2018	Axon Initial Segment Structural Plasticity is Involved in Seizure Susceptibility in a Rat Model of Cortical Dysplasia.
12/2017	[Changes in the expression of EphA5/ephrinA5 in the CA3 region of the hippocampus in rats with epilepsy and their role in the pathogenesis of temporal lobe epilepsy].
12/2017	The expression of G protein-coupled receptor kinase 5 and its interaction with dendritic marker microtubule-associated protein-2 after status epilepticus.
5/2017	Curcumin protects neuronal cells against status-epilepticus-induced hippocampal damage through induction of autophagy and inhibition of necroptosis.
1/2017	The Protective Effect of Aucubin from Eucommia ulmoides Against Status Epilepticus by Inducing Autophagy and Inhibiting Necroptosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Xiao Research Topics

Disease

42	Neoplasms (Cancer) 02/2022 - 06/2008
33	Epilepsy (Aura) 05/2022 - 02/2003
25	Temporal Lobe Epilepsy 08/2022 - 02/2003
24	Inflammation (Inflammations) 01/2022 - 01/2011
22	Colitis 01/2021 - 06/2012
20	Status Epilepticus (Complex Partial Status Epilepticus) 09/2020 - 05/2007
16	Ulcerative Colitis 01/2022 - 11/2015
13	Seizures (Absence Seizure) 05/2022 - 02/2003
11	Myasthenia Gravis 01/2022 - 01/2010
10	Colonic Neoplasms (Colon Cancer) 01/2020 - 04/2015
8	Stroke (Strokes) 10/2020 - 06/2007
8	Ischemia 01/2019 - 12/2004
7	Neoplasm Metastasis (Metastasis) 02/2022 - 04/2011
7	Breast Neoplasms (Breast Cancer) 02/2022 - 03/2007
7	Schizophrenia (Dementia Praecox) 04/2021 - 03/2009
7	Atherosclerosis 01/2019 - 11/2007
5	Ischemic Stroke 01/2021 - 01/2019
5	Wounds and Injuries (Trauma) 02/2020 - 11/2010
5	Necrosis 03/2019 - 08/2011
5	Cerebral Infarction 10/2013 - 09/2003
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 09/2010
4	Infections 12/2019 - 05/2007
4	Glioma (Gliomas) 04/2019 - 01/2018
4	Experimental Autoimmune Neuritis 04/2017 - 09/2010
4	Pain (Aches) 01/2017 - 08/2011
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2016 - 01/2014
3	Mental Disorders (Mental Disorder) 11/2022 - 04/2013
3	Asthma (Bronchial Asthma) 06/2022 - 12/2019
3	Drug Resistant Epilepsy 03/2022 - 01/2005
3	Malaria 01/2022 - 01/2019
3	Carcinogenesis 01/2022 - 05/2016
3	Partial Epilepsies (Epilepsy, Partial) 01/2022 - 11/2015
3	Hyperthermia 01/2022 - 10/2020
3	Hallucinations (Hallucination) 06/2021 - 01/2020
3	Melanoma (Melanoma, Malignant) 01/2021 - 08/2007
3	Burns 02/2020 - 09/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 08/2014
3	Body Weight (Weight, Body) 11/2019 - 05/2014
3	Hypersensitivity (Allergy) 11/2019 - 01/2013
3	Migraine Disorders (Migraine) 04/2019 - 05/2008

Drug/Important Bio-Agent (IBA)

33	Pharmaceutical PreparationsIBA 01/2022 - 04/2012
28	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2003
25	Pilocarpine (Ocusert)FDA LinkGeneric 01/2021 - 02/2003
18	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2011
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
12	Messenger RNA (mRNA)IBA 09/2020 - 02/2003
10	HydrogelsIBA 01/2022 - 01/2014
9	Therapeutic UsesIBA 01/2022 - 02/2009
9	CytokinesIBA 01/2020 - 08/2013
8	LipidsIBA 02/2022 - 12/2005
8	CurcuminIBA 03/2021 - 10/2015
7	ChitosanIBA 01/2022 - 07/2014
7	Fibroins (Fibroin)IBA 01/2022 - 01/2019
7	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020 - 07/2009
7	LithiumIBA 12/2017 - 01/2011
7	Small Interfering RNA (siRNA)IBA 01/2017 - 12/2008
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 01/2019
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2022 - 05/2007
5	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2011
5	Glutathione (Reduced Glutathione)IBA 01/2022 - 01/2018
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2016
5	AlginatesIBA 01/2022 - 07/2014
5	Antipsychotic Agents (Antipsychotics)IBA 03/2020 - 03/2009
5	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 08/2013
5	Dextrans (Dextran)FDA Link 01/2020 - 08/2013
5	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 08/2012
5	Lithium ChlorideIBA 02/2019 - 08/2008
5	CamptothecinIBA 01/2018 - 07/2009
4	MagnesiumIBA 01/2022 - 05/2007
4	Caspase 3 (Caspase-3)IBA 01/2022 - 06/2005
4	Hyaluronic Acid (Hyaluronan)IBA 03/2021 - 11/2015
4	Biological ProductsIBA 01/2021 - 01/2015
4	Long Noncoding RNAIBA 01/2021 - 03/2015
4	PolymersIBA 01/2020 - 09/2017
4	Dextran SulfateIBA 01/2020 - 05/2013
4	Poloxamer (Poloxamer 407)IBA 01/2020 - 04/2015
4	EnzymesIBA 01/2020 - 01/2008
4	oxidized low density lipoproteinIBA 01/2019 - 06/2011
4	ProdrugsIBA 10/2018 - 09/2014
4	Glycoproteins (Glycoprotein)IBA 01/2018 - 06/2012
4	Peroxidase (Myeloperoxidase)IBA 07/2014 - 05/2013
3	Antimicrobial PeptidesIBA 01/2022 - 06/2008
3	RNA (Ribonucleic Acid)IBA 09/2021 - 01/2020
3	Retinaldehyde (Retinal)IBA 06/2021 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 10/2013
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2019 - 01/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 08/2008
3	Drug CarriersIBA 01/2019 - 04/2015
3	MicellesIBA 10/2018 - 09/2017

Therapy/Procedure

44	Therapeutics 05/2022 - 09/2007
15	Drug Therapy (Chemotherapy) 01/2022 - 03/2007
9	Oral Administration 02/2022 - 01/2014
7	Radiotherapy 01/2022 - 10/2015
5	Percutaneous Nephrolithotomy 03/2021 - 11/2015
4	Combination Drug Therapy (Combination Chemotherapy) 03/2021 - 10/2015
3	Phototherapy (Light Therapy) 01/2022 - 11/2020
3	Photochemotherapy (Photodynamic Therapy) 01/2022 - 03/2019
3	Vitrectomy 01/2021 - 12/2018
3	Rhizotomy 01/2020 - 11/2019